New Compound SLU-PP-332 Shows Potential to Mimic Exercise Benefits

Researchers have developed a compound that could offer the physical advantages of exercise, potentially aiding those unable to engage in physical activity.

Researchers have developed compounds mimicking exercise effects, potentially treating muscle atrophy and neurodegenerative diseases.
The compound SLU-PP-332 activates estrogen-related receptors, enhancing muscle cells' metabolism and growth.
Experiments with mice showed increased endurance and a shift towards fatigue-resistant muscle fibers.
New compounds are being developed to potentially treat obesity, heart failure, and neurodegenerative diseases like Alzheimer’s.
The research, presented at ACS Spring 2024, could pave the way for new treatments for those unable to exercise due to various conditions.